questionsmedicales.fr
Composés chimiques organiques
Composés nitrés
Nitrophénols
Nitrophénols : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Nitrophénols : Questions médicales les plus fréquentes",
"headline": "Nitrophénols : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Nitrophénols : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-30",
"dateModified": "2025-04-25",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Nitrophénols"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Composés nitrés",
"url": "https://questionsmedicales.fr/mesh/D009574",
"about": {
"@type": "MedicalCondition",
"name": "Composés nitrés",
"code": {
"@type": "MedicalCode",
"code": "D009574",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.640"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Dinitrophénols",
"alternateName": "Dinitrophenols",
"url": "https://questionsmedicales.fr/mesh/D004140",
"about": {
"@type": "MedicalCondition",
"name": "Dinitrophénols",
"code": {
"@type": "MedicalCode",
"code": "D004140",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.640.743.304"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "2,4-Dinitro-phénol",
"alternateName": "2,4-Dinitrophenol",
"url": "https://questionsmedicales.fr/mesh/D019297",
"about": {
"@type": "MedicalCondition",
"name": "2,4-Dinitro-phénol",
"code": {
"@type": "MedicalCode",
"code": "D019297",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.640.743.304.250"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "2-Bromométhyl-4-nitro-phénol",
"alternateName": "2-Hydroxy-5-nitrobenzyl Bromide",
"url": "https://questionsmedicales.fr/mesh/D015077",
"about": {
"@type": "MedicalCondition",
"name": "2-Bromométhyl-4-nitro-phénol",
"code": {
"@type": "MedicalCode",
"code": "D015077",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.640.743.400"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Niclofolan",
"alternateName": "Niclofolan",
"url": "https://questionsmedicales.fr/mesh/D009533",
"about": {
"@type": "MedicalCondition",
"name": "Niclofolan",
"code": {
"@type": "MedicalCode",
"code": "D009533",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.640.743.600"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Nitroxinil",
"alternateName": "Nitroxinil",
"url": "https://questionsmedicales.fr/mesh/D009611",
"about": {
"@type": "MedicalCondition",
"name": "Nitroxinil",
"code": {
"@type": "MedicalCode",
"code": "D009611",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.640.743.620"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Picrates",
"alternateName": "Picrates",
"url": "https://questionsmedicales.fr/mesh/D010851",
"about": {
"@type": "MedicalCondition",
"name": "Picrates",
"code": {
"@type": "MedicalCode",
"code": "D010851",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.640.743.690"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Tolcapone",
"alternateName": "Tolcapone",
"url": "https://questionsmedicales.fr/mesh/D000077867",
"about": {
"@type": "MedicalCondition",
"name": "Tolcapone",
"code": {
"@type": "MedicalCode",
"code": "D000077867",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.640.743.845"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Nitrophénols",
"alternateName": "Nitrophenols",
"code": {
"@type": "MedicalCode",
"code": "D009596",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Sk Aftabul Alam",
"url": "https://questionsmedicales.fr/author/Sk%20Aftabul%20Alam",
"affiliation": {
"@type": "Organization",
"name": "Department of Microbiology, The University of Burdwan, Golapbag, Burdwan, West Bengal 713104 India."
}
},
{
"@type": "Person",
"name": "Pradipta Saha",
"url": "https://questionsmedicales.fr/author/Pradipta%20Saha",
"affiliation": {
"@type": "Organization",
"name": "Department of Microbiology, The University of Burdwan, Golapbag, Burdwan, West Bengal 713104 India."
}
},
{
"@type": "Person",
"name": "Yu Wang",
"url": "https://questionsmedicales.fr/author/Yu%20Wang",
"affiliation": {
"@type": "Organization",
"name": "Shanghai Key Laboratory of Agricultural Genetics and Breeding, Agro-Biotechnology Research Institute, Shanghai Academy of Agricultural Sciences, Shanghai, 201106, China."
}
},
{
"@type": "Person",
"name": "Jin Li",
"url": "https://questionsmedicales.fr/author/Jin%20Li",
"affiliation": {
"@type": "Organization",
"name": "Institute for Environmental and Climate Research, Jinan University, Guangzhou 511443, China; Guangdong-Hongkong-Macau Joint Laboratory of Collaborative Innovation for Environmental Quality, Guangzhou 511443, China."
}
},
{
"@type": "Person",
"name": "Peizeng Yang",
"url": "https://questionsmedicales.fr/author/Peizeng%20Yang",
"affiliation": {
"@type": "Organization",
"name": "Department of Environmental Science and Engineering, Nanjing Agricultural University, Nanjing 210095, China."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Maackia amurensis seed lectin (MASL) and soluble human podoplanin (shPDPN) sequence analysis and effects on human oral squamous cell carcinoma (OSCC) cell migration and viability.",
"datePublished": "2024-04-03",
"url": "https://questionsmedicales.fr/article/38583233",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.bbrc.2024.149881"
}
},
{
"@type": "ScholarlyArticle",
"name": "Elevated ratio of C-type lectin-like receptor 2 level and platelet count (C2PAC) aids in the diagnosis of post-operative venous thromboembolism in IDH-wildtype gliomas.",
"datePublished": "2023-01-21",
"url": "https://questionsmedicales.fr/article/36706720",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.thromres.2023.01.018"
}
},
{
"@type": "ScholarlyArticle",
"name": "Development of an automated chemiluminescence enzyme immunoassay for the measurement of soluble C-type lectin-like receptor 2 (sCLEC-2) and molecular forms of sCLEC-2 measured in patient plasma.",
"datePublished": "2024-10-30",
"url": "https://questionsmedicales.fr/article/39475059",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/09537104.2024.2420949"
}
},
{
"@type": "ScholarlyArticle",
"name": "Sialic Acid Mimetic Microglial Sialic Acid-Binding Immunoglobulin-like Lectin Agonism: Potential to Restore Retinal Homeostasis and Regain Visual Function in Age-Related Macular Degeneration.",
"datePublished": "2023-12-16",
"url": "https://questionsmedicales.fr/article/38139861",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ph16121735"
}
},
{
"@type": "ScholarlyArticle",
"name": "Comparison of skin mucus lectins among longtooth grouper Epinephelus bruneus and giant grouper E. lanceolatus as well as the hybrid, Kue-Tama, and their binding abilities to the skin fluke Benedeniaepinepheli.",
"datePublished": "2023-12-10",
"url": "https://questionsmedicales.fr/article/38086469",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.dci.2023.105113"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Composés chimiques organiques",
"item": "https://questionsmedicales.fr/mesh/D009930"
},
{
"@type": "ListItem",
"position": 3,
"name": "Composés nitrés",
"item": "https://questionsmedicales.fr/mesh/D009574"
},
{
"@type": "ListItem",
"position": 4,
"name": "Nitrophénols",
"item": "https://questionsmedicales.fr/mesh/D009596"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Nitrophénols - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Nitrophénols",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-09",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Nitrophénols",
"description": "Comment diagnostiquer une intoxication aux nitrophénols ?\nQuels tests sont utilisés pour évaluer l'exposition ?\nQuels symptômes indiquent une intoxication ?\nLes nitrophénols sont-ils détectables par imagerie ?\nY a-t-il des marqueurs biologiques spécifiques ?",
"url": "https://questionsmedicales.fr/mesh/D009596?mesh_terms=Lectins&page=63#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Nitrophénols",
"description": "Quels sont les symptômes d'une exposition aiguë ?\nLes nitrophénols provoquent-ils des effets chroniques ?\nComment les nitrophénols affectent-ils le système respiratoire ?\nY a-t-il des symptômes spécifiques chez les enfants ?\nLes symptômes varient-ils selon la dose ?",
"url": "https://questionsmedicales.fr/mesh/D009596?mesh_terms=Lectins&page=63#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Nitrophénols",
"description": "Comment prévenir l'exposition aux nitrophénols ?\nLes travailleurs doivent-ils être formés ?\nQuelles sont les mesures de sécurité en laboratoire ?\nLes nitrophénols sont-ils réglementés ?\nComment gérer les déversements de nitrophénols ?",
"url": "https://questionsmedicales.fr/mesh/D009596?mesh_terms=Lectins&page=63#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Nitrophénols",
"description": "Quel est le traitement principal en cas d'intoxication ?\nDes antidotes existent-ils pour les nitrophénols ?\nComment traiter les irritations cutanées causées par les nitrophénols ?\nLe charbon actif est-il utile en cas d'ingestion ?\nQuand faut-il hospitaliser un patient exposé ?",
"url": "https://questionsmedicales.fr/mesh/D009596?mesh_terms=Lectins&page=63#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Nitrophénols",
"description": "Quelles complications peuvent survenir après une exposition ?\nLes effets sont-ils réversibles ?\nY a-t-il un risque de cancer lié aux nitrophénols ?\nComment surveiller les complications à long terme ?\nLes complications varient-elles selon l'âge ?",
"url": "https://questionsmedicales.fr/mesh/D009596?mesh_terms=Lectins&page=63#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Nitrophénols",
"description": "Quels sont les principaux facteurs de risque d'exposition ?\nLes antécédents médicaux influencent-ils le risque ?\nLes enfants sont-ils plus à risque ?\nL'environnement joue-t-il un rôle ?\nLes habitudes de vie influencent-elles le risque ?",
"url": "https://questionsmedicales.fr/mesh/D009596?mesh_terms=Lectins&page=63#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une intoxication aux nitrophénols ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'historique d'exposition et des tests sanguins pour détecter les nitrophénols."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer l'exposition ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des analyses de sang et d'urine peuvent être effectuées pour mesurer les niveaux de nitrophénols."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une intoxication ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des maux de tête, des nausées, et des troubles respiratoires."
}
},
{
"@type": "Question",
"name": "Les nitrophénols sont-ils détectables par imagerie ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, l'imagerie ne détecte pas les nitrophénols; des tests biochimiques sont nécessaires."
}
},
{
"@type": "Question",
"name": "Y a-t-il des marqueurs biologiques spécifiques ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la présence de métabolites spécifiques dans l'urine peut indiquer une exposition."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une exposition aiguë ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes aigus incluent des vertiges, des nausées, et des irritations cutanées."
}
},
{
"@type": "Question",
"name": "Les nitrophénols provoquent-ils des effets chroniques ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une exposition chronique peut entraîner des troubles neurologiques et hépatiques."
}
},
{
"@type": "Question",
"name": "Comment les nitrophénols affectent-ils le système respiratoire ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent provoquer des irritations des voies respiratoires et des difficultés respiratoires."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes spécifiques chez les enfants ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les enfants peuvent présenter des symptômes plus graves, comme des convulsions et des vomissements."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon la dose ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la gravité des symptômes dépend de la dose et de la durée d'exposition."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'exposition aux nitrophénols ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des équipements de protection individuelle et suivre les protocoles de sécurité."
}
},
{
"@type": "Question",
"name": "Les travailleurs doivent-ils être formés ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une formation sur les risques et les mesures de sécurité est essentielle."
}
},
{
"@type": "Question",
"name": "Quelles sont les mesures de sécurité en laboratoire ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des hottes, des gants et des lunettes de protection lors de la manipulation."
}
},
{
"@type": "Question",
"name": "Les nitrophénols sont-ils réglementés ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, leur utilisation est réglementée pour minimiser les risques d'exposition."
}
},
{
"@type": "Question",
"name": "Comment gérer les déversements de nitrophénols ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des kits de déversement et suivre les protocoles d'urgence appropriés."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal en cas d'intoxication ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement principal est l'élimination de l'exposition et le soutien symptomatique."
}
},
{
"@type": "Question",
"name": "Des antidotes existent-ils pour les nitrophénols ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas d'antidote spécifique; le traitement est symptomatique."
}
},
{
"@type": "Question",
"name": "Comment traiter les irritations cutanées causées par les nitrophénols ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il faut rincer la zone affectée à l'eau et appliquer des crèmes apaisantes."
}
},
{
"@type": "Question",
"name": "Le charbon actif est-il utile en cas d'ingestion ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le charbon actif peut être administré pour réduire l'absorption en cas d'ingestion."
}
},
{
"@type": "Question",
"name": "Quand faut-il hospitaliser un patient exposé ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hospitalisation est nécessaire en cas de symptômes graves ou d'exposition prolongée."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir après une exposition ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des lésions hépatiques, des troubles neurologiques et respiratoires."
}
},
{
"@type": "Question",
"name": "Les effets sont-ils réversibles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être réversibles, mais d'autres peuvent être permanentes."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque de cancer lié aux nitrophénols ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études suggèrent un potentiel cancérigène, mais des recherches supplémentaires sont nécessaires."
}
},
{
"@type": "Question",
"name": "Comment surveiller les complications à long terme ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des examens médicaux réguliers et des tests fonctionnels sont recommandés pour le suivi."
}
},
{
"@type": "Question",
"name": "Les complications varient-elles selon l'âge ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les enfants et les personnes âgées peuvent être plus vulnérables aux complications."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque d'exposition ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les travailleurs en chimie, les laboratoires et les sites industriels sont à risque élevé."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux influencent-ils le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents de maladies hépatiques ou respiratoires augmentent le risque."
}
},
{
"@type": "Question",
"name": "Les enfants sont-ils plus à risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, en raison de leur taille et de leur métabolisme, les enfants sont plus vulnérables."
}
},
{
"@type": "Question",
"name": "L'environnement joue-t-il un rôle ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, vivre près d'industries utilisant des nitrophénols augmente le risque d'exposition."
}
},
{
"@type": "Question",
"name": "Les habitudes de vie influencent-elles le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines habitudes, comme le tabagisme, peuvent exacerber les effets des nitrophénols."
}
}
]
}
]
}
Maackia amurensis lectins serve as research and botanical agents that bind to sialic residues on proteins. For example, M. amurensis seed lectin (MASL) targets the sialic acid modified podoplanin (PDP...
Podoplanin (PDPN) is known to induce platelet aggregation via interacting with the C-type lectin-like receptor-2 on platelets and is involved in postoperative venous thromboembolism (VTE) formation. I...
Forty-four patients harboring high grade gliomas, treated surgically at the Department of Neurosurgery, Niigata University from April 2018 to August 2020, were included. Patients with high grade gliom...
IDH-wildtype glioma patients highly expressed PDPN (P < 0.001) compared to IDH-mutant glioma patients. In total, 9 (20.5 %) patients were diagnosed with VTE during the follow-up period, of which 8 pat...
Platelet activation is strongly involved in the development of VTE in patients with IDH-wildtype high grade gliomas, and C2PAC index is a potential marker to detect VTE formation after surgery....
Soluble CLEC-2 is anticipated to have various clinical applications as a novel biomarker for in vivo platelet activation, assessable using plasma obtained through routine sampling procedures. While sC...
Age-related macular degeneration (AMD), a leading cause of visual loss and dysfunction worldwide, is a disease initiated by genetic polymorphisms that impair the negative regulation of complement. Pro...
Interspecific hybrids of farm-raised fish are becoming popular in aquaculture owing to their advantages over pure species, including improved growth and higher resistance to infectious diseases. Kue-T...
Aphrocallistes vastus lectin (AVL) is a Ca...
Cutaneous T-cell lymphoma (CTCL) is an uncommon type of lymphoma involving malignant skin-resident or skin-homing T cells. Canine epitheliotropic lymphoma (EL) is the most common form of CTCL in dogs,...
The coronavirus disease (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has impacted public health globally. As the glycosylation of viral envelope glycopr...
Clinical symptoms of systemic lupus erythematosus (SLE), such as atherosclerosis and related cardiovascular diseases, are caused by inflammatory cytokines and endothelial cell damage. The serum sialic...
Soluble C-type lectin-like receptor 2 (sCLEC-2) is a new biomarker for platelet activation, which can be easily measured by usual blood collection. We conducted the CLECSTRO, a prospective, observatio...
The participants are patients with AIS/TIA and control patients required for differentiation from AIS/TIA. The target population is 600, including the patients and controls, who would be recruited fro...
This study was approved by the Ethical Committee of the University of Yamanashi as the central ethical committee in agreement with the ethical committees of all collaborative stroke centres. Informed ...
NCT05579405, UMIN000048954....